首页 > 最新文献

Revista Colombiana de Reumatología (English Edition)最新文献

英文 中文
Characterization of patients with idiopathic interstitial pulmonary disease and capillary and laboratory findings in two health institutions in Medellín, Colombia: A descriptive study 哥伦比亚麦德林市两家医疗机构中特发性间质性肺疾病患者的特征以及毛细血管和实验室检查结果:描述性研究
Pub Date : 2024-01-01 DOI: 10.1016/j.rcreue.2024.04.002
María Paulina Villa Saldarriaga , Yessica Andrea Barrera Marín , Jennifer Posada Caro , Juliana Gómez Mesa , Felipe Carrasco Vélez , Libia María Rodríguez Padilla , Felipe Campo Campo , Carlos Jaime Velásquez Franco , Miguel Antonio Mesa Navas , María Fernanda Álvarez Barreneche

Introduction

Interstitial lung disease (ILD) usually has a poor therapeutic response and prognosis. One of the methods that could help in the diagnosis and optimize the management of these patients is capillaroscopy. The study aimed to determine the clinical and capillaroscopic characteristics of patients with ILD and the frequency of findings suggestive of autoimmune disease.

Materials and methods

A descriptive observational study that evaluated patients with ILD treated between 2010 and 2019 without a previous diagnosis of autoimmune disease. An interview, capillaroscopy, and laboratory tests were performed.

Results

28 patients were evaluated, 16 (57.1%) were women and 17 (60.7%) had hypertension. Three patients (10.7%) reported morning stiffness for more than 60 minutes and there was one unexplained digital edema. There were no telangiectasias, Raynaud’s phenomenon, mechanic’s hands, sclerodactyly or Gottron’s sign, or ANAS titres greater than 1:80. The rest of the laboratory tests were negative in 100% of the patients. In the capillaroscopies, 13 (46.4%) patients had a normal capillaroscopic pattern, and 15 (53.6%) had capillaroscopic abnormalities of undetermined significance. There were none with a pattern of systemic sclerosis or similar.

Conclusions

No laboratory or capillaroscopy findings were found that suggested interstitial disease with autoimmune features, possibly due to the low prevalence of the disease, its high mortality, and underdiagnosis. These findings reinforce the concept of capillaroscopic normality in patients with non-autoimmune ILD and call for an active search for ILD with autoimmune features for prognostic purposes.

导言间质性肺病(ILD)的治疗反应和预后通常较差。毛细血管镜检查是有助于诊断和优化治疗这些患者的方法之一。该研究旨在确定 ILD 患者的临床和毛细血管镜特征,以及提示自身免疫性疾病的检查结果的频率。结果28名患者接受了评估,其中16人(57.1%)为女性,17人(60.7%)患有高血压。3名患者(10.7%)晨僵时间超过60分钟,1名患者出现不明原因的数字水肿。患者没有毛细血管扩张、雷诺现象、机械手、硬皮症或戈特龙征,ANAS滴度也没有超过1:80。其余的实验室检查结果在 100%的患者中均为阴性。在毛细血管镜检查中,13 例(46.4%)患者的毛细血管镜检查结果正常,15 例(53.6%)患者的毛细血管镜检查结果异常,但意义不明。结论 没有发现任何实验室或毛细血管镜检查结果显示间质性疾病具有自身免疫特征,这可能是由于该病发病率低、死亡率高以及诊断不足所致。这些发现强化了非自身免疫性间质性肺病患者毛细血管镜检查正常的概念,并呼吁积极寻找具有自身免疫特征的间质性肺病,以达到预后目的。
{"title":"Characterization of patients with idiopathic interstitial pulmonary disease and capillary and laboratory findings in two health institutions in Medellín, Colombia: A descriptive study","authors":"María Paulina Villa Saldarriaga ,&nbsp;Yessica Andrea Barrera Marín ,&nbsp;Jennifer Posada Caro ,&nbsp;Juliana Gómez Mesa ,&nbsp;Felipe Carrasco Vélez ,&nbsp;Libia María Rodríguez Padilla ,&nbsp;Felipe Campo Campo ,&nbsp;Carlos Jaime Velásquez Franco ,&nbsp;Miguel Antonio Mesa Navas ,&nbsp;María Fernanda Álvarez Barreneche","doi":"10.1016/j.rcreue.2024.04.002","DOIUrl":"10.1016/j.rcreue.2024.04.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Interstitial lung disease (ILD) usually has a poor therapeutic response and prognosis. One of the methods that could help in the diagnosis and optimize the management of these patients is capillaroscopy. The study aimed to determine the clinical and capillaroscopic characteristics of patients with ILD and the frequency of findings suggestive of autoimmune disease.</p></div><div><h3>Materials and methods</h3><p>A descriptive observational study that evaluated patients with ILD treated between 2010 and 2019 without a previous diagnosis of autoimmune disease. An interview, capillaroscopy, and laboratory tests were performed.</p></div><div><h3>Results</h3><p>28 patients were evaluated, 16 (57.1%) were women and 17 (60.7%) had hypertension. Three patients (10.7%) reported morning stiffness for more than 60 minutes and there was one unexplained digital edema. There were no telangiectasias, Raynaud’s phenomenon, mechanic’s hands, sclerodactyly or Gottron’s sign, or ANAS titres greater than 1:80. The rest of the laboratory tests were negative in 100% of the patients. In the capillaroscopies, 13 (46.4%) patients had a normal capillaroscopic pattern, and 15 (53.6%) had capillaroscopic abnormalities of undetermined significance. There were none with a pattern of systemic sclerosis or similar.</p></div><div><h3>Conclusions</h3><p>No laboratory or capillaroscopy findings were found that suggested interstitial disease with autoimmune features, possibly due to the low prevalence of the disease, its high mortality, and underdiagnosis. These findings reinforce the concept of capillaroscopic normality in patients with non-autoimmune ILD and call for an active search for ILD with autoimmune features for prognostic purposes.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 1","pages":"Pages 44-50"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141052658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrobulbar optic neuritis in a patient with enteropathic spondyloarthritis treated with tumour necrosis factor inhibitors 一名接受肿瘤坏死因子抑制剂治疗的肠病性脊柱关节炎患者出现视网膜神经炎
Pub Date : 2024-01-01 DOI: 10.1016/j.rcreue.2022.02.002
Ben Ayed Hiba , Fazaa Alia , Ouenniche Kmar , Miladi Saoussen , Sellami Mariem , Souabni Leila , Kassab Selma , Chekili Selma , Ben Abdelghani Kaouther , Laatar Ahmed

Optic neuritis is a rare ocular manifestation of inflammatory bowel diseases and spondyloarthritis. The use of tumour necrosis alpha inhibitors to treat these conditions remains possible. We report a case of a 62-year-old-woman with a 17 year-history of axial and peripheral spondyloarthritis associated with Crohn's disease, treated with tumour necrosis alpha inhibitors, who developed an asymmetric retrobulbar optic neuritis that promptly responded to a high dose of steroids.

视神经炎是炎症性肠病和脊柱关节炎的一种罕见眼部表现。使用肿瘤坏死α抑制剂治疗这些疾病仍然是可行的。我们报告了一例 62 岁女性患者的病例,她患有与克罗恩病相关的轴性和外周脊柱关节炎,病史长达 17 年,曾接受过肿瘤坏死α抑制剂治疗。
{"title":"Retrobulbar optic neuritis in a patient with enteropathic spondyloarthritis treated with tumour necrosis factor inhibitors","authors":"Ben Ayed Hiba ,&nbsp;Fazaa Alia ,&nbsp;Ouenniche Kmar ,&nbsp;Miladi Saoussen ,&nbsp;Sellami Mariem ,&nbsp;Souabni Leila ,&nbsp;Kassab Selma ,&nbsp;Chekili Selma ,&nbsp;Ben Abdelghani Kaouther ,&nbsp;Laatar Ahmed","doi":"10.1016/j.rcreue.2022.02.002","DOIUrl":"https://doi.org/10.1016/j.rcreue.2022.02.002","url":null,"abstract":"<div><p>Optic neuritis is a rare ocular manifestation of inflammatory bowel diseases and spondyloarthritis. The use of tumour necrosis alpha inhibitors to treat these conditions remains possible. We report a case of a 62-year-old-woman with a 17 year-history of axial and peripheral spondyloarthritis associated with Crohn's disease, treated with tumour necrosis alpha inhibitors, who developed an asymmetric retrobulbar optic neuritis that promptly responded to a high dose of steroids.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 1","pages":"Pages 84-87"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141244588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe interstitial lung disease in a patient with anti-PL7 antisynthetase syndrome 一名抗PL7抗异烟酸酶综合征患者的严重间质性肺病
Pub Date : 2024-01-01 DOI: 10.1016/j.rcreue.2024.04.001
Sebastián Molina-Ríos , Gerardo Quintana-López

Antisynthetase syndrome is a rare disease, with varying degrees of lung, muscle, joint, and skin involvement. Due to the introduction of new diagnostic tests, it is possible to detect the disease earlier and to determine the best treatment strategy. However, in our country the availability of these tests is limited. We present the case of a patient with antisynthetase syndrome associated with anti-PL7 antibodies in whom, thanks to the early identification of these antibodies, timely initiation of treatment for the disease was achieved.

抗合成代谢酶综合征是一种罕见疾病,患者的肺部、肌肉、关节和皮肤都会受到不同程度的影响。由于引入了新的诊断检测方法,人们可以更早地发现这种疾病,并确定最佳治疗策略。然而,在我国,这些检测方法的可用性非常有限。我们介绍了一例伴有抗PL7抗体的抗异烟酸酶综合征患者的病例,由于及早发现了这些抗体,该患者得以及时开始接受治疗。
{"title":"Severe interstitial lung disease in a patient with anti-PL7 antisynthetase syndrome","authors":"Sebastián Molina-Ríos ,&nbsp;Gerardo Quintana-López","doi":"10.1016/j.rcreue.2024.04.001","DOIUrl":"10.1016/j.rcreue.2024.04.001","url":null,"abstract":"<div><p>Antisynthetase syndrome is a rare disease, with varying degrees of lung, muscle, joint, and skin involvement. Due to the introduction of new diagnostic tests, it is possible to detect the disease earlier and to determine the best treatment strategy. However, in our country the availability of these tests is limited. We present the case of a patient with antisynthetase syndrome associated with anti-PL7 antibodies in whom, thanks to the early identification of these antibodies, timely initiation of treatment for the disease was achieved.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 1","pages":"Pages 103-108"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141056837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Splenic infarction as presentation of antiphospholipid syndrome and systemic lupus erythematosus: A case report 以脾梗死为表现的抗磷脂综合征和系统性红斑狼疮:病例报告
Pub Date : 2024-01-01 DOI: 10.1016/j.rcreue.2022.07.004
Johan Azañero-Haro , Liliana Chambi , Alonso Soto

Splenic infarction is a rare condition usually associated with systemic conditions. Antiphospholipid syndrome (APS) is an autoimmune condition that can present as abdominal pain due to splenic infarction. We describe a patient with systemic lupus erythematosus, admitted due to acute abdominal pain. Abdominal CT scan showed splenic infarction, and tests for antiphospholipid and anti-β2-glycoprotein I antibodies were positive. The pathophysiology and clinical presentation of splenic infarction associated with APS is discussed, emphasizing the importance of including this entity in the differential diagnosis of abdominal pain of uncertain cause in patients with systemic conditions.

脾梗塞是一种罕见的疾病,通常与全身性疾病有关。抗磷脂综合征(APS)是一种自身免疫性疾病,可表现为脾梗塞引起的腹痛。我们描述了一名因急性腹痛入院的系统性红斑狼疮患者。腹部 CT 扫描显示脾梗塞,抗磷脂抗体和抗β2-糖蛋白 I 抗体检测呈阳性。本文讨论了与 APS 相关的脾梗死的病理生理学和临床表现,强调了将这种疾病纳入全身性疾病患者不明原因腹痛的鉴别诊断中的重要性。
{"title":"Splenic infarction as presentation of antiphospholipid syndrome and systemic lupus erythematosus: A case report","authors":"Johan Azañero-Haro ,&nbsp;Liliana Chambi ,&nbsp;Alonso Soto","doi":"10.1016/j.rcreue.2022.07.004","DOIUrl":"10.1016/j.rcreue.2022.07.004","url":null,"abstract":"<div><p>Splenic infarction is a rare condition usually associated with systemic conditions. Antiphospholipid syndrome (APS) is an autoimmune condition that can present as abdominal pain due to splenic infarction. We describe a patient with systemic lupus erythematosus, admitted due to acute abdominal pain. Abdominal CT scan showed splenic infarction, and tests for antiphospholipid and anti-β2-glycoprotein I antibodies were positive. The pathophysiology and clinical presentation of splenic infarction associated with APS is discussed, emphasizing the importance of including this entity in the differential diagnosis of abdominal pain of uncertain cause in patients with systemic conditions.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 1","pages":"Pages 127-132"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141141984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determination of the 99th percentile of anticardiolipin and anti-β2 glycoprotein I antibodies in an institution in the city of Medellin, Colombia 哥伦比亚麦德林市一家医疗机构抗心磷脂和抗β2糖蛋白I抗体第99百分位数的测定
Pub Date : 2024-01-01 DOI: 10.1016/j.rcreue.2022.01.003
Gustavo Adolfo Castilla Agudelo , Libia María Rodríguez Padilla , Sergio Jaramillo Velásquez , Lady Johanna Hernández Zapata , Miguel Antonio Mesa Navas , María Fernanda Álvarez Barreneche , Carlos Jaime Velásquez Franco

Introduction

Antiphospholipid syndrome diagnosis requires abnormal results of lupus anticoagulant and high titles of anticardiolipin (aCL) and β2glycoprotein I (anti-β2GPI) antibodies. The latter immunological tests lack a standard threshold in clinical practice.

Objective

To determine the 99th percentile of aCL and anti-β2GPI in healthy volunteers.

Materials and methods

This cross-sectional study reviewed antibody titles of anticardiolipin and β2glycoprotein I (IgG and IgM by enzyme-linked immunosorbent assay) in forty-nine healthy blood donors in Medellin, Colombia. Sociodemographic and immunological variables are also assessed. Antibody titles are described in median and interquartile range and the 99th percentile was estimated.

Results

We analysed samples from 16 men and 33 women. We found that the upper limits of the reference range (99th percentile) of aCL and anti-β2GPI were: aCL IgM: 18.0, aCL IgG: 16.1, anti-β2GPI IgM: 16.4, and anti- β2GPI IgG: 6.9.

Conclusions

The upper limits obtained differ greatly from the arbitrary classification values suggested in the international guidelines, taking into account that values greater than 40 international units are usually required, and the values identified in this study are between 6.9 and 18 international units. We suggest conducting additional studies that validate cut-off points according to the percentiles explored in this work.

引言 抗磷脂综合征的诊断需要狼疮抗凝物的异常结果以及高水平的抗心磷脂(aCL)和β2糖蛋白I(抗β2GPI)抗体。这项横断面研究审查了哥伦比亚麦德林市 49 名健康献血者的抗心磷脂和β2糖蛋白 I(IgG 和 IgM,通过酶联免疫吸附测定法)抗体题目。此外,还对社会人口学和免疫学变量进行了评估。结果我们分析了 16 名男性和 33 名女性的样本。我们发现 aCL 和抗β2GPI 的参考范围上限(第 99 百分位数)分别为:aCL IgM:18.0,aCL IgG:16.1,抗β2GPI IgM:16.4,抗β2GPI IgG:6.9。结论考虑到通常需要大于 40 国际单位的数值,而本研究中确定的数值介于 6.9 和 18 国际单位之间,因此获得的上限与国际指南中建议的任意分类值相差很大。我们建议开展更多研究,根据本研究中探讨的百分位数来验证分界点。
{"title":"Determination of the 99th percentile of anticardiolipin and anti-β2 glycoprotein I antibodies in an institution in the city of Medellin, Colombia","authors":"Gustavo Adolfo Castilla Agudelo ,&nbsp;Libia María Rodríguez Padilla ,&nbsp;Sergio Jaramillo Velásquez ,&nbsp;Lady Johanna Hernández Zapata ,&nbsp;Miguel Antonio Mesa Navas ,&nbsp;María Fernanda Álvarez Barreneche ,&nbsp;Carlos Jaime Velásquez Franco","doi":"10.1016/j.rcreue.2022.01.003","DOIUrl":"10.1016/j.rcreue.2022.01.003","url":null,"abstract":"<div><h3>Introduction</h3><p>Antiphospholipid syndrome diagnosis requires abnormal results of lupus anticoagulant and high titles of anticardiolipin (aCL) and β2glycoprotein I (anti-β2GPI) antibodies. The latter immunological tests lack a standard threshold in clinical practice.</p></div><div><h3>Objective</h3><p>To determine the 99th percentile of aCL and anti-β2GPI in healthy volunteers.</p></div><div><h3>Materials and methods</h3><p>This cross-sectional study reviewed antibody titles of anticardiolipin and β2glycoprotein I (IgG and IgM by enzyme-linked immunosorbent assay) in forty-nine healthy blood donors in Medellin, Colombia. Sociodemographic and immunological variables are also assessed. Antibody titles are described in median and interquartile range and the 99th percentile was estimated.</p></div><div><h3>Results</h3><p>We analysed samples from 16 men and 33 women. We found that the upper limits of the reference range (99th percentile) of aCL and anti-β2GPI were: aCL IgM: 18.0, aCL IgG: 16.1, anti-β2GPI IgM: 16.4, and anti- β2GPI IgG: 6.9.</p></div><div><h3>Conclusions</h3><p>The upper limits obtained differ greatly from the arbitrary classification values suggested in the international guidelines, taking into account that values greater than 40 international units are usually required, and the values identified in this study are between 6.9 and 18 international units. We suggest conducting additional studies that validate cut-off points according to the percentiles explored in this work.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 1","pages":"Pages 3-10"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141048062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency of Sjögren’s syndrome in patients with dry symptoms using two histopathological methods 使用两种组织病理学方法分析干燥症状患者的斯约格伦综合征发病率
Pub Date : 2024-01-01 DOI: 10.1016/j.rcreue.2022.03.009
Jairo Cajamarca-Barón , Diana Guavita-Navarro , Ana María Gutiérrez Cura , Paula Cristina Castro Quiroga , Héctor Cubides , Ana María Arredondo , Alejandro Escobar , José Fernando Polo Nieto , Claudia Ibáñez , Adriana Rojas-Villarraga

Introduction and objective

The criteria for Sjögren’s syndrome (SS) classification (ACR/EULAR 2016), include labial salivary gland (LSG) biopsy using the focus score (FS). But, in some cases it continues to be based on Chisholm and Mason (CM). Our objective was to evaluate the frequency of SS in patients with dry symptoms using FS and CM and to evaluate the degree of inter and intra-observer concordance of the histopathological reading by both methods.

Materials and methods

Cross-sectional study design. All patients with dry symptoms and studies to perform the SS classification criteria (2016) were included. The samples were independently evaluated by two readers. Descriptive statistics was used for the calculation of SS frequency. Agreement (Cohen’s Kappa coefficient) was analysed (STATA) for each test (CM and FS). Ethics approval was obtained.

Results

92 patients were included. According to the 2016 criteria, SS was reported in 26.1% patients in whom FS was used and in 34.8% patients in whom CM was used. The degree of intra-observer concordance for the diagnosis of FLS was perfect and moderate-high for observers. Inter-observer agreement was substantial, with kappa values ​​of .77 FS and .75 CM.

Conclusions

FS method is a more detailed and specific score that facilitates correct classification. The use of CM as a histopathological classificatory method for SS includes more patients when compared with FS. These results are of relevance to standardise the reading of LSG biopsy in specialized services attending SS patients.

导言和目标斯约格伦综合征(SS)的分类标准(ACR/EULAR,2016 年)包括使用病灶评分(FS)进行唇唾液腺(LSG)活检。但在某些情况下,仍以 Chisholm 和 Mason(CM)为基础。我们的目的是使用 FS 和 CM 评估干燥症状患者出现 SS 的频率,并评估这两种方法的组织病理学读数在观察者之间和观察者内部的一致程度。纳入所有有干燥症状的患者和执行 SS 分类标准(2016 年)的研究。样本由两名阅读者独立评估。描述性统计用于计算SS频率。对每次测试(CM 和 FS)的一致性(Cohen's Kappa coefficient)进行了分析(STATA)。结果92名患者被纳入研究。根据2016年的标准,使用FS的患者中有26.1%报告了SS,使用CM的患者中有34.8%报告了SS。观察者内部对FLS诊断的一致性程度为完全一致,观察者的一致性程度为中等偏上。观察者之间的一致性很高,卡帕值分别为 0.77 FS 和 0.75 CM。与 FS 相比,使用 CM 作为 SS 的组织病理学分类方法可纳入更多患者。这些结果对于规范SS患者专科医院的LSG活检阅读具有重要意义。
{"title":"Frequency of Sjögren’s syndrome in patients with dry symptoms using two histopathological methods","authors":"Jairo Cajamarca-Barón ,&nbsp;Diana Guavita-Navarro ,&nbsp;Ana María Gutiérrez Cura ,&nbsp;Paula Cristina Castro Quiroga ,&nbsp;Héctor Cubides ,&nbsp;Ana María Arredondo ,&nbsp;Alejandro Escobar ,&nbsp;José Fernando Polo Nieto ,&nbsp;Claudia Ibáñez ,&nbsp;Adriana Rojas-Villarraga","doi":"10.1016/j.rcreue.2022.03.009","DOIUrl":"10.1016/j.rcreue.2022.03.009","url":null,"abstract":"<div><h3>Introduction and objective</h3><p>The criteria for Sjögren’s syndrome (SS) classification (ACR/EULAR 2016), include labial salivary gland (LSG) biopsy using the focus score (FS). But, in some cases it continues to be based on Chisholm and Mason (CM). Our objective was to evaluate the frequency of SS in patients with dry symptoms using FS and CM and to evaluate the degree of inter and intra-observer concordance of the histopathological reading by both methods.</p></div><div><h3>Materials and methods</h3><p>Cross-sectional study design. All patients with dry symptoms and studies to perform the SS classification criteria (2016) were included. The samples were independently evaluated by two readers. Descriptive statistics was used for the calculation of SS frequency. Agreement (Cohen’s Kappa coefficient) was analysed (STATA) for each test (CM and FS). Ethics approval was obtained.</p></div><div><h3>Results</h3><p>92 patients were included. According to the 2016 criteria, SS was reported in 26.1% patients in whom FS was used and in 34.8% patients in whom CM was used. The degree of intra-observer concordance for the diagnosis of FLS was perfect and moderate-high for observers. Inter-observer agreement was substantial, with kappa values ​​of .77 FS and .75 CM.</p></div><div><h3>Conclusions</h3><p>FS method is a more detailed and specific score that facilitates correct classification. The use of CM as a histopathological classificatory method for SS includes more patients when compared with FS. These results are of relevance to standardise the reading of LSG biopsy in specialized services attending SS patients.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 1","pages":"Pages 29-37"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141045092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of social media use on depression in patients with ankylosing spondylitis: Results of a cross-sectional study 社交媒体的使用对强直性脊柱炎患者抑郁情绪的影响:横断面研究结果
Pub Date : 2024-01-01 DOI: 10.1016/j.rcreue.2022.05.004
Sadettin Uslu , Nihan Cüzdan , İpek Türk

Introduction

Social media is a powerful tool in providing information and support for patients with chronic diseases. The aim was to assess the link between using social media and depression in a sample population of Turkish ankylosing spondylitis (AS) patients.

Materials and methods

The patients completed a self-administered questionnaire, which was designed by the authors. Their demographic data, educational status, diagnosis, and favorite social network were also recorded. The Beck Depression Inventory-IA amended (revised) (BDI-IA-Turkish) was used to screen the AS patients for depression.

Results

A total of 155 AS patients were included in the study. The depression scores of the patients who used the Internet (12.18 ± 6.85) and social media (12.35 ± 6.90) were compared with those who did not (27.19 ± 10.51 vs. 25.20 ± 11.66) and a significant difference (p  0.001) was found. Smartphone users were in the majority (73.5%). WhatsApp was the preferred social network (66.5%), followed by Facebook (52.9%), Instagram (52.3%), Twitter (19.4%) and Pinterest (5.8%). Social media users and non-users were similar in age, gender, educational level and marital status. There were no significant differences in terms of the type and duration of social media use with depression score.

Conclusion

The results of this cross-sectional study confirmed that using social media can help patients with AS to cope with or be less affected by depression. Finding the most appropriate and commonly used form of social media may be an important concept for stewardship in health policies.

简介:社交媒体是为慢性病患者提供信息和支持的有力工具。本研究旨在评估土耳其强直性脊柱炎(AS)患者中使用社交媒体与抑郁之间的联系。同时还记录了他们的人口统计学数据、教育状况、诊断和最喜欢的社交网络。研究采用贝克抑郁量表-IA修订版(BDI-IA-Turkish)对强直性脊柱炎患者进行抑郁筛查。使用互联网(12.18 ± 6.85)和社交媒体(12.35 ± 6.90)的患者与不使用互联网和社交媒体的患者(27.19 ± 10.51 vs. 25.20 ± 11.66)的抑郁评分进行了比较,发现两者之间存在显著差异(p ≤ 0.001)。智能手机用户占大多数(73.5%)。WhatsApp 是首选社交网络(66.5%),其次是 Facebook(52.9%)、Instagram(52.3%)、Twitter(19.4%)和 Pinterest(5.8%)。社交媒体用户和非用户在年龄、性别、教育程度和婚姻状况方面相似。结论这项横断面研究的结果证实,使用社交媒体可以帮助强直性脊柱炎患者应对抑郁或减少抑郁的影响。找到最合适、最常用的社交媒体形式可能是卫生政策管理的一个重要概念。
{"title":"Impact of social media use on depression in patients with ankylosing spondylitis: Results of a cross-sectional study","authors":"Sadettin Uslu ,&nbsp;Nihan Cüzdan ,&nbsp;İpek Türk","doi":"10.1016/j.rcreue.2022.05.004","DOIUrl":"https://doi.org/10.1016/j.rcreue.2022.05.004","url":null,"abstract":"<div><h3>Introduction</h3><p>Social media is a powerful tool in providing information and support for patients with chronic diseases. The aim was to assess the link between using social media and depression in a sample population of Turkish ankylosing spondylitis (AS) patients.</p></div><div><h3>Materials and methods</h3><p>The patients completed a self-administered questionnaire, which was designed by the authors. Their demographic data, educational status, diagnosis, and favorite social network were also recorded. The Beck Depression Inventory-IA amended (revised) (BDI-IA-Turkish) was used to screen the AS patients for depression.</p></div><div><h3>Results</h3><p>A total of 155 AS patients were included in the study. The depression scores of the patients who used the Internet (12.18<!--> <!-->±<!--> <!-->6.85) and social media (12.35<!--> <!-->±<!--> <!-->6.90) were compared with those who did not (27.19<!--> <!-->±<!--> <!-->10.51 vs. 25.20<!--> <!-->±<!--> <!-->11.66) and a significant difference (<em>p</em> <!-->≤<!--> <!-->0.001) was found. Smartphone users were in the majority (73.5%). WhatsApp was the preferred social network (66.5%), followed by Facebook (52.9%), Instagram (52.3%), Twitter (19.4%) and Pinterest (5.8%). Social media users and non-users were similar in age, gender, educational level and marital status. There were no significant differences in terms of the type and duration of social media use with depression score.</p></div><div><h3>Conclusion</h3><p>The results of this cross-sectional study confirmed that using social media can help patients with AS to cope with or be less affected by depression. Finding the most appropriate and commonly used form of social media may be an important concept for stewardship in health policies.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 1","pages":"Pages 38-43"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141244576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of anti-C1q antibodies, adiponectin and HLA II genotype in Colombian patients with systemic lupus erythematosus with lupus nephritis 哥伦比亚系统性红斑狼疮合并狼疮性肾炎患者体内抗 C1q 抗体、脂肪连接蛋白和 HLA II 基因型的关系
Pub Date : 2024-01-01 DOI: 10.1016/j.rcreue.2022.03.006
Sebastián Molina-Ríos , Gerardo Quintana-López , Gustavo Aroca , Eduardo Egea , Antonio Iglesias-Gamarra

Objective

To establish associations between the development of lupus nephritis (LN) and the expression of antibodies against C1q (anti-C1q) and serum adiponectin as these biomarkers have been previously postulated to be associated with the presence of LN.

Materials and methods

A case–control study nested in a cohort was chosen. Patients with SLE with renal involvement were included. Measurement of antibodies against C1q, levels of adiponectin, and HLA expression DRB1 and DQB1 were evaluated. We searched for possible associations between the measured biomarkers and allelic HLA types found.

Results

One hundred and six patients were recruited with LN with a mean age of 35 years. Mean adiponectin levels were 16.9 μg/mL, and 60% of patients presented anti-C1q positivity. HLA DRB1*0404 and DRB1*1101 are protective factors for LN (OR: .42, p = .0030 and OR: 0.49, p = .046 respectively). HLA DRB1*0701 (OR: 3.15, p = .0452) and DRB1*0802 (OR: 8.3, p = .020) are susceptibility factors for LN. There was a tendency for association between anti-C1q positivity and high levels of adiponectin with type IV LN (OR 2.3 [95% CI: 0.68–8.2] and (OR: 2.67 [95% CI: .76–9.9] respectively). There was a tendency for association between anti-C1q positivity and HLA expression DRB1*0701 (OR 2.7 [95% CI: .81–11.5]), as well as high levels of adiponectin and HLA expression DRB1*0404 (OR 3.03 [95% CI: .92–12.8]). No association was found between anti-C1q and adiponectin with the expression of HLA DRB1*1501. There was positive correlation between levels of anti-C1q and the activity index in renal biopsy.

Conclusions

In the Colombian population there is a tendency for association of anti-C1q with the expression of HLA DRB1*07; however, the expression of other HLA II genes known as risk factors for LN, was not associated with the expression of anti-C1q, adiponectin or any specific type of LN.

目的确定狼疮性肾炎(LN)的发生与 C1q 抗体(抗 C1q)和血清脂肪连接蛋白的表达之间的关系,因为这些生物标志物以前曾被推测与 LN 的存在有关。研究对象包括肾脏受累的系统性红斑狼疮患者。对 C1q 抗体、脂肪连接蛋白水平以及 HLA 表达 DRB1 和 DQB1 进行了评估。结果 共招募了 16 名 LN 患者,平均年龄为 35 岁。平均脂联素水平为 16.9 μg/mL,60% 的患者呈抗 C1q 阳性。HLA DRB1*0404 和 DRB1*1101 是 LN 的保护因素(OR:0.42,p = .0030 和 OR:0.49,p = .046)。HLA DRB1*0701(OR:3.15,p = .0452)和 DRB1*0802(OR:8.3,p = .020)是 LN 的易感因素。抗 C1q 阳性和高水平的脂联素与 IV 型 LN 有关联趋势(OR 分别为 2.3 [95% CI: 0.68-8.2] 和 (OR: 2.67 [95% CI: .76-9.9])。抗 C1q 阳性与 HLA 表达 DRB1*0701 之间存在关联趋势(OR:2.7 [95% CI:.81-11.5]),高水平的脂肪连素与 HLA 表达 DRB1*0404 之间也存在关联趋势(OR:3.03 [95% CI:.92-12.8])。抗 C1q 和脂肪连蛋白与 HLA DRB1*1501 的表达之间没有关联。结论 在哥伦比亚人群中,抗 C1q 与 HLA DRB1*07 的表达存在相关性;然而,被称为 LN 危险因素的其他 HLA II 基因的表达与抗 C1q、脂肪连接蛋白或任何特定类型 LN 的表达无关。
{"title":"Association of anti-C1q antibodies, adiponectin and HLA II genotype in Colombian patients with systemic lupus erythematosus with lupus nephritis","authors":"Sebastián Molina-Ríos ,&nbsp;Gerardo Quintana-López ,&nbsp;Gustavo Aroca ,&nbsp;Eduardo Egea ,&nbsp;Antonio Iglesias-Gamarra","doi":"10.1016/j.rcreue.2022.03.006","DOIUrl":"https://doi.org/10.1016/j.rcreue.2022.03.006","url":null,"abstract":"<div><h3>Objective</h3><p>To establish associations between the development of lupus nephritis (LN) and the expression of antibodies against C1q (anti-C1q) and serum adiponectin as these biomarkers have been previously postulated to be associated with the presence of LN.</p></div><div><h3>Materials and methods</h3><p>A case–control study nested in a cohort was chosen. Patients with SLE with renal involvement were included. Measurement of antibodies against C1q, levels of adiponectin, and HLA expression DRB1 and DQB1 were evaluated. We searched for possible associations between the measured biomarkers and allelic HLA types found.</p></div><div><h3>Results</h3><p>One hundred and six patients were recruited with LN with a mean age of 35 years. Mean adiponectin levels were 16.9<!--> <!-->μg/mL, and 60% of patients presented anti-C1q positivity. HLA DRB1*0404 and DRB1*1101 are protective factors for LN (OR: .42, <em>p</em> <!-->=<!--> <!-->.0030 and OR: 0.49, <em>p</em> <!-->=<!--> <!-->.046 respectively). HLA DRB1*0701 (OR: 3.15, <em>p</em> <!-->=<!--> <!-->.0452) and DRB1*0802 (OR: 8.3, <em>p</em> <!-->=<!--> <!-->.020) are susceptibility factors for LN. There was a tendency for association between anti-C1q positivity and high levels of adiponectin with type IV LN (OR 2.3 [95% CI: 0.68–8.2] and (OR: 2.67 [95% CI: .76–9.9] respectively). There was a tendency for association between anti-C1q positivity and HLA expression DRB1*0701 (OR 2.7 [95% CI: .81–11.5]), as well as high levels of adiponectin and HLA expression DRB1*0404 (OR 3.03 [95% CI: .92–12.8]). No association was found between anti-C1q and adiponectin with the expression of HLA DRB1*1501. There was positive correlation between levels of anti-C1q and the activity index in renal biopsy.</p></div><div><h3>Conclusions</h3><p>In the Colombian population there is a tendency for association of anti-C1q with the expression of HLA DRB1*07; however, the expression of other HLA II genes known as risk factors for LN, was not associated with the expression of anti-C1q, adiponectin or any specific type of LN.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 1","pages":"Pages 11-17"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141244590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IgG4-related autoimmune pancreatitis: A neoplasm mimicker IgG4相关自身免疫性胰腺炎:一种肿瘤模拟物
Pub Date : 2024-01-01 DOI: 10.1016/j.rcreue.2022.05.005
Diana C. Quintero-González, Marcela Muñoz-Urbano, Adriana-Lucía Vanegas-García, Gloria Vásquez
{"title":"IgG4-related autoimmune pancreatitis: A neoplasm mimicker","authors":"Diana C. Quintero-González,&nbsp;Marcela Muñoz-Urbano,&nbsp;Adriana-Lucía Vanegas-García,&nbsp;Gloria Vásquez","doi":"10.1016/j.rcreue.2022.05.005","DOIUrl":"https://doi.org/10.1016/j.rcreue.2022.05.005","url":null,"abstract":"","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 1","pages":"Pages 135-137"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141239362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autoimmunity in patients with silicone breast implants: An exploratory review 硅胶乳房植入物患者的自身免疫:探索性综述
Pub Date : 2024-01-01 DOI: 10.1016/j.rcreue.2022.12.004
Erika Alexandra Barroso da Silva , Lorena Vásquez Ortiz , Camila Aragón Salleg , Ignacio Briceño Balcázar , Eduardo Tuta Quintero , Ximena Urrea , Luis Gustavo Celis , Juan Pimentel

Silicone breast implants are considered highly immunogenic adjuvant devices in the human body, however, the medical evidence linking the development of autoimmune diseases and Adjuvant-induced Inflammatory Autoimmunity Syndrome (ASIA) in patients using breast implants is not conclusive. In the following manuscript, an exploratory systematic review was carried out using the Scopus and PubMed databases, including analytical and descriptive observational studies with no time limit. Twenty-one articles were included, which showed that the main autoimmune diseases associated with this group of patients were undifferentiated diseases of connective tissue; most of the patients presented symptoms such as chronic fatigue, arthralgia, fever, and myalgia. The objective of this study is to synthesize and analyse the current medical literature on the frequency of rheumatological diseases concomitant with ASIA in users of silicone breast implants.

硅胶乳房假体被认为是人体内高免疫原性的佐剂装置,然而,使用乳房假体的患者发生自身免疫性疾病和佐剂诱发炎症性自身免疫综合征(ASIA)的医学证据并不确凿。在接下来的手稿中,我们使用 Scopus 和 PubMed 数据库进行了一项探索性系统综述,包括分析性和描述性观察研究,没有时间限制。研究共收录了 21 篇文章,结果显示与这组患者相关的自身免疫性疾病主要是结缔组织未分化疾病;大多数患者表现出慢性疲劳、关节痛、发热和肌痛等症状。本研究的目的是综合并分析目前关于硅胶乳房假体使用者伴随 ASIA 的风湿病频率的医学文献。
{"title":"Autoimmunity in patients with silicone breast implants: An exploratory review","authors":"Erika Alexandra Barroso da Silva ,&nbsp;Lorena Vásquez Ortiz ,&nbsp;Camila Aragón Salleg ,&nbsp;Ignacio Briceño Balcázar ,&nbsp;Eduardo Tuta Quintero ,&nbsp;Ximena Urrea ,&nbsp;Luis Gustavo Celis ,&nbsp;Juan Pimentel","doi":"10.1016/j.rcreue.2022.12.004","DOIUrl":"10.1016/j.rcreue.2022.12.004","url":null,"abstract":"<div><p>Silicone breast implants are considered highly immunogenic adjuvant devices in the human body, however, the medical evidence linking the development of autoimmune diseases and Adjuvant-induced Inflammatory Autoimmunity Syndrome (ASIA) in patients using breast implants is not conclusive. In the following manuscript, an exploratory systematic review was carried out using the Scopus and PubMed databases, including analytical and descriptive observational studies with no time limit. Twenty-one articles were included, which showed that the main autoimmune diseases associated with this group of patients were undifferentiated diseases of connective tissue; most of the patients presented symptoms such as chronic fatigue, arthralgia, fever, and myalgia. The objective of this study is to synthesize and analyse the current medical literature on the frequency of rheumatological diseases concomitant with ASIA in users of silicone breast implants.</p></div>","PeriodicalId":101099,"journal":{"name":"Revista Colombiana de Reumatología (English Edition)","volume":"31 1","pages":"Pages 57-67"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141055293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista Colombiana de Reumatología (English Edition)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1